Filana Therapeutics, Inc.

NasdaqCM: FLNA · Healthcare

Positivity Index

#2,702 / 6,774

Global

#940 / 4,000

United States

Positivity Score

21,217

Rank→

PosiRed: 1 active red flag (highest severity 6/10) View flag history →

PosiRed · red flag

Stock exchange listing-rule deficiency notice (8-K Item 3.01)

The company reported in a Form 8-K (Item 3.01) filed on 18 Sep 2026 that its stock exchange notified it of not meeting a continued-listing rule. Continued non-compliance can lead to delisting.

More details →

Filana Therapeutics, Inc. — Overview & Financial Snapshot

Filana Therapeutics, Inc. (NasdaqCM: FLNA) is a Healthcare company, ranked #2,702 of 6,774 companies globally and #940 of 4,000 in United States on PositoAI, with a Positivity Score of 21,217. Its market capitalisation is ₹298.26 Cr ($31.60M), P/E ratio is -0.8 and P/B ratio is 0.50. It currently has 1 active red flag (PosiRed) and no yellow flags (PosiYellow) on record.

For financial statements, ratio trends and score history, Go Deep →

What does Filana Therapeutics, Inc. do?

Filana Therapeutics, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is in Phase 3 clinical trial to treat Alzheimer's disease; and investigational diagnostic product candidate is SavaDx, an…

What is Filana Therapeutics, Inc.'s P/E and P/B ratio?

Filana Therapeutics, Inc. has a P/E ratio of -0.8 and a P/B ratio of 0.50.

What is Filana Therapeutics, Inc.'s debt-to-equity ratio?

Filana Therapeutics, Inc. has a debt-to-equity ratio of 0.00.

How much does Filana Therapeutics, Inc. owe compared with what it owns?

Filana Therapeutics, Inc. owes $0.39 for every $1 it owns (balance sheet Jun 2026), which is low.

What is Filana Therapeutics, Inc.'s Positivity rank?

Filana Therapeutics, Inc. is ranked #2,702 of 6,774 companies globally and #940 of 4,000 in United States on PositoAI, with a Positivity Score of 21,217.

Does Filana Therapeutics, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?

Yes. Filana Therapeutics, Inc. has 1 active red flag (PosiRed) on record: Stock exchange listing-rule deficiency notice (8-K Item 3.01) (dated 18 Sep 2026). It has no yellow flags.

Where can I read the latest news about Filana Therapeutics, Inc.?

Recent headlines about Filana Therapeutics, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.

Does Filana Therapeutics, Inc. have a PositoAI PosiShot or QR code?

Yes. A dated PosiShot of Filana Therapeutics, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.